Ken Griffin's position in Dexcom is currently worth $178 Million. That's 0.17% of their equity portfolio (130th largest holding). The first Dexcom trade was made in Q2 2013. Since then Ken Griffin bought shares 64 more times and sold shares on 50 occasions. The stake costed the investor $146 Million, netting the investor a gain of 22% so far.